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TECHNICAL NOTE
Successful production of sterile pyrogen-free electrolyte
solution by ultrafiltration
LEE W. HENDERSON AND ERMINIA BEANS
Department of Medicine, Division of Nephrology, Veterans Administration Hospital and Unh'ersity of California,
San Diego, California
Sterile pyrogen-free solutions in large quantity
are required for medical procedures such as perito-
neal dialysis (50 to 100 liters/treatment given i.p.)
and hemofiltration, a new potentially useful process
of convective blood cleansing (40 to 70 liters/treat-
ment given i.v.). These solutions contribute signifi-
cantly to the overall cost of these procedures. In an
effort to reduce this cost, the following method of
solution production was developed and tested.
Methods
Water treated for routine use in artificial kidney
dialysis fluid was utilized (treated by reverse os-
mosis with a final "polish" using a deionizer). A
resistivity of at least I megohm-cm is a commonly
used criterion of satisfactory quality [1]. Water
processed in this manner when tested with limulus
lysate (supplied by DIFCO, Cat. #3361-59) and cul-
ture, however, showed the presence of both pyro-
gen and small numbers of gram-negative bacteria.
Growth of bacteria on the downstream side of the
reverse osmosis membrane system and, more com-
monly, in the resin beds of the deionizer has been
reported by others [2] and must account for their
presence in the product water. Processed water was
combined with a single concentrate of electrolytes
and glucose (supplied by Erika Co., Cat. #08-8110-
2) to achieve the following concentrations: sodium,
140 mEq/liter; chloride, 106 mEq/liter; acetate, 41
mEq/Iiter; potassium, 2.0 mEq/liter; calcium, 3.5
mEq/liter; magnesium, 1.5 mEq/liter; and glucose,
100 mg/100 ml.
Forty-liter batches were prepared in glass car-
Received for publication December 20, 1977;
and in revised form Febniary 20. 1978.
0085.2538/78/001t1_0522 $01.00
© 1978 by the International Society of Nephrology.
522
boys equipped with stainless steel caps which con-
tained a cotton-plugged air vent and a dip tube
through which to retrieve the solution. Quality con-
trol of the solution composition was then carried
out. In this instance, osmolality and conductivity
were measured to assure appropriate dilution of the
concentrate. Next, using the flow circuit shown in
Fig. 1, a 1.6 m2 hollow-fiber ultrafilter made of an
anisotropic polyelectrolyte membrane (XP-50 1.6
m2 hollow-fiber ultrafilter for biological use, sup-
plied by Amicon Corporation, Lexington, Mass.)
was used to remove pyrogens and bacteria. Each
ultrafilter was initially qualified for possible 'pin
hole" leaks or broken fibers by ultrafiltering blue
dextran (2 x l0 daltons) solution and visually ex-
amining the ultrafiltrate for color. The assembled ul-
trafilter was checked to be free of pyrogen by using
the limulus lysate assay on saline solution left
standing in the fiber lumen and in the casing. Re-
moval of the pyrogens and bacteria from the elec-
trolyte solution was accomplished by ultrafiltration
(500 to 600 mm Hg driving pressure) into a second
40-liter glass carboy that had been heat sterilized
and depyrogenized (200° C for 12 hr). Sterility of
the produced solution was checked with routine
aerobic and anaerobic cultures taken through the
dip tube at the top of the carboy, and pyrogen was
checked for with the limulus lysate assay. Bacterial
pyrogen deliberately introduced upstream of the
membrane was totally excluded from the product
solution, indicating a "cutoff" for the XP-50 ultra-
filter that satisfactorily blocks passage of pyrogen
and bacteria. The system was filled with formalin
when not in use. The sterilant was introduced
through the ultrafilter in a manner entirely analo-
gous to that used to prepare the sterile pyrogen-free
solution. This preserved the pyrogen-free status of
that portion of the system downstream of the filter.
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40-liter sterile pyrogen-free
recipient carboy
Results
Solution qualified as free of bacteria and negative
to limulus lysate was introduced as diluting fluid in-
to the blood path of an extracorporeal circuit used
for hemofiltration at a rate of 200 cc/mm (Fig. 2).
The same kind of ultrafilter used to depyrogenize
the solution originally was then used to remove the
excess fluid so that volunteer patient blood volume
was not altered. Thirty to fifty liters of this diluting
fluid was delivered into the blood path over the
course of the 4- to 5-hr period of hemofiltration treat-
ment. To date, more than 8,000 liters of solution pre-
pared in this manner have been used in seven pa-
tient volunteers with no untoward responses.
Two 40-liter carboys prepared in this manner and
sampled at 10 weeks were sterile and pyrogen-free.
No formal study of filter life was undertaken;
rather, ultrafilters used to prepare the solution were
discarded after preparation of 500 to 800 liters.
There is no reason to expect that filter life could not
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Fig. 2. Diagrammatic representation of hemofiltration. This shows a process whereby
whole blood leaving the patient at a flow rate Qb is diluted with saline solution at a flow
rate of Q and is then ultrafiltered at a rate Q, such that Qf just matches Qd.
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Fig. 1. Diagrammatic sketch of membrane depyrogenation process.
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be prolonged easily by back-flushing the membrane
to wash away the accumulated debris.
The cost of solution prepared in this manner, in-
cluding aerobic and anaerobic culture, limulus ly-
sate assay, cost of the XP-50 ultrafilter, and person-
nel time was less than a dollar ($0.90/liter) as con-
trasted with over two dollars ($2.50/liter) for
commercially supplied solution purchased direct
from the supplier with no intermediary markup.
Discussion
Pyrogen in water solution is generally considered
to be of large molecular weight (i.e., in the millions)
with smaller molecular weight fragments being non-
toxic 13—5]. The XP-50 membrane passes inulin
(5,200 daltons) completely, but rejects (99+%) albu-
min (60,000 daltons) [6]. The limulus lysate assay is
reported to be sensitive to the presence of gram-
negative endotoxin at a concentration of l0 to
l0_14 /Lg/ml [7].a Presence of endotoxin at concen-
trations below the sensitivity of the method might
be expected to show up clinically as a pyrogen re-
sponse if the large volumes of solution utilized
brought the total delivery of endotoxin to a toxic
level in the blood stream. No such event was noted
for volumes of up to 40 liters delivered in a 5-hr pe-
riod.
The limulus lysate test determines the presence
of gram-negative bacterial products and would not
be expected to show the presence of pyrogens such
as colloidal iron, silica, clay, etc. Reverse osmosis
treatment of the water would remove such con-
'taminants, however, and their presence in dialysis
fluid concentrate where substantial concern over
trace presence of any extraneous substances is high
would be unlikely. Rabbit assay for pyrogen which
would be expected to reveal gram-negative and oth-
er nonbacterial pyrogens, although not used rou-
tinely, has proved to be negative on spot check. In
like manner, the growth of gram-positive organisms
in the water processing system as a result of retro-
grade contamination of the reverse osmosis mem-
brane or the deionizer resin beds after removal of
the chlorine by the latter is equally unlikely in view
of their more demanding growth requirements. In
addition, should this event occur, one might reason-
ably expect that both gram-positive bacteria and
their wall fragments would be of a molecular size
1t should be noted that the limulus amebocyte lysate assay for
pyrogen has now been licensed by the Food and Drug Adminis-
tration as an alternative for the rabbit pyrogen test for detecting
pyrogens in biological products and medical devices [8],
comparable to their gram-negative counterparts and
hence be removed by the ultrafilter. Clearly, start-
ing water should not contain trace elements and/or
undesirable substances below the molecular weight
cutoff of the ultrafilter. Similarly, additives such as
the electrolyte concentrate should be carefully ex-
amined to assure satisfactory purity.
The cost of the ultrafilter at $125 each is high be-
cause they are made in limited numbers for supply
to an experimental protocol. Cost of these items is
highly labor intensive and could be expected to fall
substantially if large numbers are produced. Fur-
ther, the units can be back-flushed when flux rate
slows, and continued performance at 200 cmVmin
of product solution can be expected for use beyond
the 800 liter cutoff presently exercised. Ultrafilter
life may be further prolonged by adding a 0.2-p fil-
ter proximal to the ultrafilter to trap bacteria and
other particulates that may be present.
Preparation of sterile pyrogen-free peritoneal
dialysis solution with the process of reverse os-
mosis requires addition of sterile pyrogen-free elec-
trolyte concentrate to the processed water and, as
such, is inherently a more expensive process than
that described. Further, the driving pressure and/or
membrane area required to achieve satisfactory
flow rates for water in a reverse osmosis system are
substantially larger than that required for the loos-
er" XP-50 ultrafiltration membrane, making the
supporting equipment necessary to operate the lat-
ter system a good deal simpler.
There are several applications for this one-step
low-pressure filtration process for making biologi-
cally safe electrolyte solution. Peritoneal dialysis
has been roughly comparable in expense to hemo-
dialysis, due in large measure to the cost of pur-
chasing the dialysis solution. The work of Tenck-
hoff, Meston, and Shilipetar [9] to produce this so-
lution "on line" by using reverse osmosis to treat
tap water and by subsequently adding sterile pyro-
gen-free electrolyte concentrate has done much to
reduce the cost of this technique. The present meth-
od would reduce cost even more by obviating the
need for concentrate to be sterile and pyrogen-free.
If municipal tap water is of satisfactory quality from
the standpoint of trace elements, no prior water
treatment may be necessary. The ASAIO and
AAMI Kidney Standards Subcommittee has sug-
gested that tap water used in preparation of dialysis
fluid should meet the requirements for purified wa-
ter as described in the U.S. Pharmacopeia [101 with
the following additions: (1) The heavy metal content
of water shall not exceed 0.1 mg/liter. (2) The arsenic
Sterile pyrogen-free electrolyte solution 525
content shall not exceed 0.1 mg/liter. (3) The total
viable microbial count shall not exceed 100/mi. (4) If
water to be used is treated with a deionizer, then a
resistivity of the product should be greater than 1 X
106 ohm-cm at 20° C. Requirement 3 would not
apply for water used in the present process.
Hemofiltration is another area for application. At
present this technique for blood cleansing must be
considered experimental. Reports from our labora-
tory and others in Europe [11—14] on improved cor-
rection of the uremic syndrome make it likely that
hemofiltration which requires 30 to 70 liters of i.v.
saline solution per treatment will find low pressure
filtration useful to reduce treatment costs. Other
potential applications may only be speculated on.
It should be noted that although there are require-
ments in the form of good manufacturing practices
presented by the Food and Drug Administration for
solutions that are transported across state lines, it is
left to individual institutions (hospitals, pharmacies)
to control the quality of extemporaneously com-
pounded solutions as presently described. Fur-
ther, there is nothing at present in the pending Food
and Drug Administration devise legislation that spe-
cifically addresses ultrafiltration membranes used in
the manner described.
Last, the logical next step for procedures such as
peritoneal dialysis and hemofiltration is to prepare
solution by ultrafiltration for use "on line," pro-
vided suitable quality control may be maintained.
For example, two ultrafiltration membranes in se-
ries with a sampling port for serial pyrogen-testing
between the two units may be used to insure that a
broken fiber occurring in an "on line" system does
not jeopardize the safety of the patient.
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